http://www.rxpgnews.com/ Medical News and Information Thu, 21 Aug 2008 02:00:28 PST en-us http://www.rxpgnews.com/protonpumpinhibitors/Immediate-release_Omeprazole_Significantly_Reduces_1703_1703.shtml PPI Santarus, Inc. (NASDAQ:SNTS), a specialty pharmaceutical company focused on therapies for gastrointestinal diseases and disorders, today announced the publication of clinical trial results in the June 15, 2005 issue of Alimentary Pharmacology & Therapeutics, a peer-reviewed gastroenterology journal. Wed, 15 Jun 2005 00:15:00 PST http://www.rxpgnews.com/protonpumpinhibitors/Immediate-release_Omeprazole_Significantly_Reduces_1703_1703.shtml http://www.rxpgnews.com/protonpumpinhibitors/NDA_Filed_for_Omeprazole_Chewable_Tablets_1577_1577.shtml PPI Santarus, Inc. (NASDAQ:SNTS), a specialty pharmaceutical company focused on therapies for gastrointestinal diseases and disorders, today announced that it has submitted a New Drug Application (NDA) for ZEGERID(R) (omeprazole) Chewable Tablets 40 mg and 20 mg to the U.S. Food and Drug Administration (FDA). Fri, 27 May 2005 17:46:00 PST http://www.rxpgnews.com/protonpumpinhibitors/NDA_Filed_for_Omeprazole_Chewable_Tablets_1577_1577.shtml http://www.rxpgnews.com/esomeprazole/Esomeprazole_can_reduce_upper_GI_symptoms_in_patie_1454_1454.shtml Esomeprazole Results from two clinical trials, published in the American Journal of Gastroenterology, demonstrate that NEXIUM® (esomeprazole magnesium) can reduce upper gastrointestinal (GI) symptoms – such as moderate to severe pain, burning and discomfort in the upper abdomen– associated with continuous, daily use of non-steroidal anti-inflammatory drugs (NSAIDs), including selective COX-2 inhibitors. Fri, 13 May 2005 17:04:00 PST http://www.rxpgnews.com/esomeprazole/Esomeprazole_can_reduce_upper_GI_symptoms_in_patie_1454_1454.shtml